Experts: Revamped OxyContin hasn’t curbed abuse, overdoses
On Friday, Sept. 11, 2020, a U.S. Food and Drug Administration advisory panel said there’s no clear evidence that a reformulated version of the painkiller OxyContin designed to discourage abuse…